Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Helios Towers ( (GB:HTWS) ) has provided an announcement.
Helios Towers has completed the final purchases under the first tranche of its share buyback programme, acquiring 71,969 ordinary shares on 6 January 2026 at a volume-weighted average price of 163.84 pence per share across multiple trading venues. The company will cancel these shares, reducing its total shares in issue to 1,043,560,105, and will immediately move into a second tranche of the programme worth $25 million, to be executed under a non-discretionary agreement by Merrill Lynch International, a move that underscores its ongoing capital return strategy and is likely to enhance earnings per share and adjust the shareholder base metrics for disclosure purposes.
The most recent analyst rating on (GB:HTWS) stock is a Hold with a £174.00 price target. To see the full list of analyst forecasts on Helios Towers stock, see the GB:HTWS Stock Forecast page.
Spark’s Take on GB:HTWS Stock
According to Spark, TipRanks’ AI Analyst, GB:HTWS is a Neutral.
Helios Towers’ stock score is primarily driven by positive technical indicators and a robust share buyback program, which enhance shareholder value. However, the high leverage and negative revenue growth rate are significant concerns. The valuation is relatively high, which may deter some investors.
To see Spark’s full report on GB:HTWS stock, click here.
More about Helios Towers
Helios Towers plc operates in the telecommunications infrastructure sector, focusing on owning, operating and maintaining telecom towers and related passive infrastructure across emerging markets to support mobile network operators and digital connectivity growth.
Average Trading Volume: 2,310,935
Technical Sentiment Signal: Buy
Current Market Cap: £1.69B
For a thorough assessment of HTWS stock, go to TipRanks’ Stock Analysis page.

